News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
TMX Newsfile
NEWS
IN THE PRESS
Press Releases
Maxwell Biosciences Subsidiary Havih Announces Partnership with the Government of Andhra Pradesh
December 18, 2025
·
4 min read
Press Releases
Therma Bright Inc. Investee Company, InStatin Expands its Inhaled Statin Programs to include COPD (Chronic Obstructive Pulmonary Disease) as its Lead Indication.
December 18, 2025
·
5 min read
Press Releases
InMed Announces Results of 2025 Annual General and Special Meeting
December 18, 2025
·
4 min read
Press Releases
Restart Life Closes Over-Subscribed Second Tranche Financing
December 18, 2025
·
2 min read
Press Releases
Envoy Medical Reaches Enrollment Milestone in Pivotal Clinical Study of Fully Implanted Acclaim(R) Cochlear Implant
December 18, 2025
·
7 min read
Press Releases
BioHarvest Sciences Awarded $1.6 Million USD Grant from the Israeli Innovation Authority to Advance Second-Generation Botanical Synthesis Platform
December 18, 2025
·
3 min read
Press Releases
TempraMed Expands U.S. Manufacturing Capacity with New Production Facility in Florida
December 17, 2025
·
5 min read
Press Releases
NervGen Pharma Announces Filing of Form F-10 Registration Statement with The SEC Under MJDS
December 17, 2025
·
5 min read
Press Releases
Restart Life Announces Food Technology and Research Studies
December 17, 2025
·
6 min read
Press Releases
BioVaxys Announces Positive Phase 1 Clinical Study Results with Maveropepimut-S (MVP-S) in Women with Hormone Receptor Positive/HER2 Negative (HR+/HER2-) Stage II-III Breast Cancer
December 17, 2025
·
9 min read
15 Toronto St., Suite 601 Toronto ON M5C 2E3 US
Tel: 416-806-1750
Visit website
Email Us